BCM
CLBT icon

Brasada Capital Management’s Cellebrite CLBT Stock Holding History

Brasada Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-275,315
Closed -$4.91M – 148
2025
Q4 		$4.91M Sell
275,315
-2,070
-0.7% -$37.2K 0.83% 44
2025
Q3 		$5.21M Buy
277,385
+12,190
+5% +$191K 0.88% 38
2025
Q2 		$4.1M Buy
265,195
+67,482
+34% +$1.2M 0.7% 52
2025
Q1 		$3.51M Buy
+197,713
New +$4.16M 0.7% 49
2023
Q4 		– Sell
-375,332
Closed -$2.76M – 142
2023
Q3 		$2.76M Buy
375,332
+208,566
+125% +$1.57M 0.64% 44
2023
Q2 		$1.2M Buy
+166,766
New +$972K 0.26% 85

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Brasada Capital Management's CLBT Position: Q1 2026 in Review

Brasada Capital Management sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 275,315 shares — an estimated $4.91M sold.

Brasada Capital Management first reported a position in CLBT in Q2 2023 and held it in 6 quarters. The position peaked at $5.21M in Q3 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Brasada Capital Management reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Brasada Capital Management sold 275,315 Cellebrite shares in Q1 2026, an estimated $4.91M.
  • Brasada Capital Management first reported a position in Cellebrite in Q2 2023 and held it in 6 quarters.
  • Brasada Capital Management's Cellebrite position peaked at $5.21M in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Brasada Capital Management's 13F filing for Q1 2026, filed 15 May 2026.